Harnessing ROS Amplification and GSH Depletion Using a Carrier‐Free Nanodrug to Enhance Ferroptosis‐Based Cancer Therapy
Authors:
Abstract
Ferroptosis, a non‐apoptotic form of cell death characterized by the production of reactive oxygen species (ROS) and massive accumulation of lipid peroxidation (LPO), shows significant promise in cancer therapy. However, the overexpression of glutathione (GSH) at the tumor site and insufficient ROS often result in unsatisfactory therapeutic efficacy. A multistage, GSH‐consuming, and ROS‐providing carrier‐free nanodrug capable of efficiently loading copper ions (Cu2+), sorafenib (SRF), and chlorogenic acid (CGA) (Cu2+‐CGA‐SRF, CCS‐NDs) is developed to mediate enhanced ferroptosis therapy. Through a reductive intracellular environment, Cu2+ in the CCS‐NDs reacted with intracellular GSH, alleviating the antioxidant capacity of tumor tissues and triggering the release of drugs. Meanwhile, the released SRF inhibited system xc−, thereby blocking cystine uptake and reducing GSH synthesis in tumor cells. By depleting stored GSH and inhibiting its synthesis, CCS‐NDs achieved efficient GSH depletion and increased accumulation of toxic LPO. More importantly, the high concentration of CGA in the CCS‐NDs induced ROS generation, further promoting ferroptosis. Both in vitro and in vivo results demonstrated that CCS‐NDs effectively triggered ferroptosis in tumor cells by inactivating glutathione peroxidase 4 and inducing LPO. Overall, the carrier‐free nanodrug CCS‐NDs offer a promising strategy for regulating GSH and LPO levels in ferroptosis‐based cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (52003006)
- Natural Science Foundation of Anhui Province (2108085QH356)
- Anhui Medical University (XJ201909)
This publication has 29 references indexed in Scilit:
- A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapyBiomaterials, 2024
- Redox-active polyphenol nanoparticles deprive endogenous glutathione of electrons for ROS generation and tumor chemodynamic therapyActa Biomaterialia, 2023
- Stepwise responsive carboxymethyl chitosan-based nanoplatform for effective drug-resistant breast cancer suppressionCarbohydrate Polymers, 2022
- Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapyBioactive Materials, 2021
- Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapyBiomaterials, 2021
- Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathyActa Pharmaceutica Sinica B, 2021
- Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modificationBioactive Materials, 2021
- Polymeric micelles amplify tumor oxidative stresses through combining PDT and glutathione depletion for synergistic cancer chemotherapyChemical Engineering Journal, 2021
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomesCell, 2021
- Ferroptosis, a novel pharmacological mechanism of anti-cancer drugsCancer Letters, 2020